1. Home
  2. IMOS vs AORT Comparison

IMOS vs AORT Comparison

Compare IMOS & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

IMOS

ChipMOS TECHNOLOGIES INC.

HOLD

Current Price

$28.69

Market Cap

980.5M

Sector

Technology

ML Signal

HOLD

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$47.29

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMOS
AORT
Founded
1997
1984
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
980.5M
2.1B
IPO Year
N/A
1993

Fundamental Metrics

Financial Performance
Metric
IMOS
AORT
Price
$28.69
$47.29
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$49.36
AVG Volume (30 Days)
14.4K
376.1K
Earning Date
11-11-2025
11-06-2025
Dividend Yield
2.25%
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$748,307,671.00
$422,646,000.00
Revenue This Year
$5.78
$15.97
Revenue Next Year
$10.84
$10.96
P/E Ratio
$133.69
N/A
Revenue Growth
N/A
9.81
52 Week Low
$12.78
$21.97
52 Week High
$30.98
$48.25

Technical Indicators

Market Signals
Indicator
IMOS
AORT
Relative Strength Index (RSI) 57.44 60.45
Support Level $27.91 $45.41
Resistance Level $29.12 $48.25
Average True Range (ATR) 0.60 1.35
MACD -0.27 0.18
Stochastic Oscillator 40.94 80.97

Price Performance

Historical Comparison
IMOS
AORT

About IMOS ChipMOS TECHNOLOGIES INC.

ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: